Hyperliquid Strategies Q1 net profit driven by HYPE token gains

Hyperliquid Strategies

07/05/2026 22:20

Overview

US digital asset treasury platform reported Q1 net profit primarily attributable to $198.4 million in unrealized gains on HYPE tokens

Company completed disposition of most legacy biotech operations during the quarter

Validator partnership announced with Unit Labs to deepen ecosystem alignment

Outlook

Company did not provide specific financial guidance for the current quarter or full year

Result Drivers

HYPE TOKEN GAINS - Q1 net profit was primarily driven by $198.4 mln in unrealized gains on HYPE tokens

STAKING REVENUE - HYPE token holdings generated $2.6 mln in staking revenue for the quarter

BIOTECH EXIT - Completion of legacy biotech operations disposition contributed to strategic focus on digital assets

Company press release: ID:nPnbgC78ra

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
H1 Net Income
$165.40 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the blockchain & cryptocurrency peer group is "buy"

Wall Street's median 12-month price target for Hyperliquid Strategies Inc is $8.45, about 22.1% above its May 6 closing price of $6.92

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)